Stephen Hoge insider trades

Open-market stock purchases and sales by Stephen Hoge, President at Moderna, Inc, from SEC Form 4 filings since Dec 11, 2018.

Recent trades

DateStockTradeValue
Sep 15, 2026MRNA Moderna, IncSold$5.9M
Sep 15, 2026MRNA Moderna, IncBought (not open market)—
Sep 14, 2026MRNA Moderna, IncSold$5.8M
Sep 14, 2026MRNA Moderna, IncBought (not open market)—
Sep 1, 2026MRNA Moderna, IncSold (not open market)$630K
Sep 1, 2026MRNA Moderna, IncBought (not open market)—
Aug 28, 2026MRNA Moderna, IncSold (not open market)$42.3K
Aug 28, 2026MRNA Moderna, IncBought (not open market)—
Aug 27, 2026MRNA Moderna, IncSold (not open market)$104K
Aug 27, 2026MRNA Moderna, IncBought (not open market)—
Jul 15, 2026MRNA Moderna, IncSold$3.6M
Jul 15, 2026MRNA Moderna, IncBought (not open market)—
Jul 15, 2026MRNA Moderna, IncBought (not open market)—
Jun 15, 2026MRNA Moderna, IncSold$2.7M
Jun 15, 2026MRNA Moderna, IncBought (not open market)—
Jun 15, 2026MRNA Moderna, IncBought (not open market)—
Jun 1, 2026MRNA Moderna, IncBought (not open market)—
Jun 1, 2026MRNA Moderna, IncSold (not open market)$212K
May 28, 2026MRNA Moderna, IncSold (not open market)$14K
May 28, 2026MRNA Moderna, IncBought (not open market)—
May 27, 2026MRNA Moderna, IncSold (not open market)$32.7K
May 27, 2026MRNA Moderna, IncBought (not open market)—
May 15, 2026MRNA Moderna, IncSold$2.6M
May 15, 2026MRNA Moderna, IncBought (not open market)—
May 15, 2026MRNA Moderna, IncBought (not open market)—

Companies traded

  • MRNA Moderna, Inc: 469 sales, last Sep 15, 2026
  • AXLA Axcella Health Inc: other filings, last May 20, 2021

Get free alerts when Stephen Hoge files a new trade →